NO943472L - Cykloheksan-derivat, farmakologisk preparat omfattende dette, og fremgangsmåte for forebygging/behandling av sykdommer ved anvendelse av nevnte cykloheksanderivat - Google Patents

Cykloheksan-derivat, farmakologisk preparat omfattende dette, og fremgangsmåte for forebygging/behandling av sykdommer ved anvendelse av nevnte cykloheksanderivat

Info

Publication number
NO943472L
NO943472L NO943472A NO943472A NO943472L NO 943472 L NO943472 L NO 943472L NO 943472 A NO943472 A NO 943472A NO 943472 A NO943472 A NO 943472A NO 943472 L NO943472 L NO 943472L
Authority
NO
Norway
Prior art keywords
cyclohexane derivative
preventing
treating diseases
pharmacological preparation
chem
Prior art date
Application number
NO943472A
Other languages
English (en)
Other versions
NO302234B1 (no
NO943472D0 (no
Inventor
Yasuhiro Kabasawa
Fumihiro Ozaki
Keiji Ishibashi
Takashi Hasegawa
Hitoshi Oinuma
Manabu Shirato
Katsuhiro Moriya
Toshiaki Ogawa
Satoshi Katayama
Shigeru Souda
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of NO943472D0 publication Critical patent/NO943472D0/no
Publication of NO943472L publication Critical patent/NO943472L/no
Publication of NO302234B1 publication Critical patent/NO302234B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
NO943472A 1993-09-21 1994-09-19 Cykloheksanderivat og farmasöytisk preparat omfattende dette NO302234B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23453893 1993-09-21

Publications (3)

Publication Number Publication Date
NO943472D0 NO943472D0 (no) 1994-09-19
NO943472L true NO943472L (no) 1995-03-22
NO302234B1 NO302234B1 (no) 1998-02-09

Family

ID=16972600

Family Applications (1)

Application Number Title Priority Date Filing Date
NO943472A NO302234B1 (no) 1993-09-21 1994-09-19 Cykloheksanderivat og farmasöytisk preparat omfattende dette

Country Status (14)

Country Link
US (2) US5478839A (no)
EP (1) EP0644182B1 (no)
KR (1) KR0149066B1 (no)
CN (1) CN1100031C (no)
AT (1) ATE166046T1 (no)
AU (1) AU686642B2 (no)
CA (1) CA2131749A1 (no)
DE (1) DE69410198T2 (no)
FI (1) FI107155B (no)
HU (1) HU221198B1 (no)
NO (1) NO302234B1 (no)
NZ (1) NZ264480A (no)
RU (1) RU2129113C1 (no)
ZA (1) ZA947146B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999041246A1 (en) * 1998-02-11 1999-08-19 Du Pont Pharmaceuticals Company Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors
JP4838537B2 (ja) * 2005-05-25 2011-12-14 株式会社 資生堂 不全角化抑制剤、毛穴縮小剤又は肌荒れ防止・改善剤及び皮膚外用組成物
US7994190B2 (en) 2006-11-01 2011-08-09 Bristol-Myers Squibb Company Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200640A (en) * 1976-04-02 1980-04-29 Chugai Seiyaku Kabushiki Kaisha Nitric ester of N-(2-hydroxyethyl)nicotinamide and pharmaceutical use
GB9000342D0 (en) * 1990-01-08 1990-03-07 May & Baker Ltd New compositions of matter
GB9002879D0 (en) * 1990-02-08 1990-04-04 May & Baker Ltd New compositions of matter
HUT66229A (en) * 1991-10-14 1994-10-28 Eisai Co Ltd Thioformamide derivatives and process for producing them and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
HU9402702D0 (en) 1994-12-28
ZA947146B (en) 1996-03-15
RU2129113C1 (ru) 1999-04-20
AU7169694A (en) 1995-04-06
EP0644182A1 (en) 1995-03-22
FI107155B (fi) 2001-06-15
CN1106380A (zh) 1995-08-09
HUT68036A (en) 1995-05-29
DE69410198T2 (de) 1999-03-11
HU221198B1 (en) 2002-08-28
NO302234B1 (no) 1998-02-09
KR0149066B1 (ko) 1998-10-15
KR950008446A (ko) 1995-04-17
ATE166046T1 (de) 1998-05-15
DE69410198D1 (de) 1998-06-18
US5605907A (en) 1997-02-25
NZ264480A (en) 1995-07-26
RU94033470A (ru) 1996-08-10
CA2131749A1 (en) 1995-03-22
FI944207A (fi) 1995-03-22
AU686642B2 (en) 1998-02-12
FI944207A0 (fi) 1994-09-12
CN1100031C (zh) 2003-01-29
EP0644182B1 (en) 1998-05-13
NO943472D0 (no) 1994-09-19
US5478839A (en) 1995-12-26

Similar Documents

Publication Publication Date Title
DE69915004D1 (de) 5-Oxo-pyrrolidine-2-Carbonsäure-Hydroxamidderivate
CA2243591A1 (en) Halogen pyrimidines and its use thereof as parasite abatement means
DE60012751D1 (de) Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz
ATE201687T1 (de) Galanthamin-derivat, ein verfahren zu seiner herstellung und seine verwendung als medikament
DK0807630T3 (da) Heterocykliske forbindelser
DE69319764D1 (de) Verfahren zur Herstellung von Beta-Lactamderivaten und Zwischenprodukt für ihre Synthese
DE69400791D1 (de) 5-Amino-8-methyl-7-pyrrolidinylchinolin-3-Carbonsäurederivat
NO982873D0 (no) 1-metylkarbapenemderivater
ATE204868T1 (de) 2-aryl-3-aminoaryloxynaphthylverbindungen, zwischenverbindungen, zusammensetzungen und verfahren
HK1061674A1 (en) 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
DE60002558D1 (de) Derivate der Phosphonsäure zur Inhibierung von Carboxypeptidase B
NO943472L (no) Cykloheksan-derivat, farmakologisk preparat omfattende dette, og fremgangsmåte for forebygging/behandling av sykdommer ved anvendelse av nevnte cykloheksanderivat
EP0555479A4 (no)
AU657423B2 (en) Novel piperidine derivatives and process for preparation thereof